Be Part of the Solution: Vax Up!
JEMS proudly gives two thumbs up to the Ohio Department of Public Safety, Division of EMS, which, in partnership with the Mentor Fire Department, created an outstanding “Vax Up” edition of their “Be Part of the Solution” public service announcement (PSA) series. The Division of EMS created, and is encouraging distribution, of this PSA as a resource to encourage EMS providers to receive the COVID-19 vaccine, to highlight the importance of vaccination to all public safety personnel and to the community, and to encourage the populations in the upcoming phases of the vaccination plan to be immunized ...
Source: JEMS Patient Care - January 14, 2021 Category: Emergency Medicine Authors: A.J. Heightman, MPA, EMT-P Tags: Commentary Coronavirus Spotlight EMS EMT Medicine Paramedic Source Type: news

Be Part of the Solution: Vax Up!
JEMS proudly gives two thumbs up to the Ohio Department of Public Safety, Division of EMS, which, in partnership with the Mentor Fire Department, created an outstanding “Vax Up” edition of their “Be Part of the Solution” public service announcement (PSA) series. The Division of EMS created, and is encouraging distribution, of this PSA as a resource to encourage EMS providers to receive the COVID-19 vaccine, to highlight the importance of vaccination to all public safety personnel and to the community, and to encourage the populations in the upcoming phases of the vaccination plan to be immunized ...
Source: JEMS Administration and Leadership - January 14, 2021 Category: Emergency Medicine Authors: A.J. Heightman, MPA, EMT-P Tags: Commentary Coronavirus Spotlight EMS EMT Medicine Paramedic Source Type: news

Be Part of the Solution: Vax Up!
JEMS proudly gives two thumbs up to the Ohio Department of Public Safety, Division of EMS, which, in partnership with the Mentor Fire Department, created an outstanding “Vax Up” edition of their “Be Part of the Solution” public service announcement (PSA) series. The Division of EMS created, and is encouraging distribution, of this PSA as a resource to encourage EMS providers to receive the COVID-19 vaccine, to highlight the importance of vaccination to all public safety personnel and to the community, and to encourage the populations in the upcoming phases of the vaccination plan to be immunized ...
Source: JEMS Latest News - January 14, 2021 Category: Emergency Medicine Authors: A.J. Heightman, MPA, EMT-P Tags: Commentary Coronavirus Spotlight EMS EMT Medicine Paramedic Source Type: news

Be Part of the Solution: Vax Up!
JEMS proudly gives two thumbs up to the Ohio Department of Public Safety, Division of EMS, which, in partnership with the Mentor Fire Department, created an outstanding “Vax Up” edition of their “Be Part of the Solution” public service announcement (PSA) series. The Division of EMS created, and is encouraging distribution, of this PSA as a resource to encourage EMS providers to receive the COVID-19 vaccine, to highlight the importance of vaccination to all public safety personnel and to the community, and to encourage the populations in the upcoming phases of the vaccination plan to be immunized ...
Source: JEMS: Journal of Emergency Medical Services News - January 14, 2021 Category: Emergency Medicine Authors: A.J. Heightman, MPA, EMT-P Tags: Commentary Coronavirus Spotlight EMS EMT Medicine Paramedic Source Type: news

Be Part of the Solution: Vax Up!
JEMS proudly gives two thumbs up to the Ohio Department of Public Safety, Division of EMS, which, in partnership with the Mentor Fire Department, created an outstanding “Vax Up” edition of their “Be Part of the Solution” public service announcement (PSA) series. The Division of EMS created, and is encouraging distribution, of this PSA as a resource to encourage EMS providers to receive the COVID-19 vaccine, to highlight the importance of vaccination to all public safety personnel and to the community, and to encourage the populations in the upcoming phases of the vaccination plan to be immunized ...
Source: JEMS Operations - January 14, 2021 Category: Emergency Medicine Authors: A.J. Heightman, MPA, EMT-P Tags: Commentary Coronavirus Spotlight EMS EMT Medicine Paramedic Source Type: news

Be Part of the Solution: Vax Up!
JEMS proudly gives two thumbs up to the Ohio Department of Public Safety, Division of EMS, which, in partnership with the Mentor Fire Department, created an outstanding “Vax Up” edition of their “Be Part of the Solution” public service announcement (PSA) series. The Division of EMS created, and is encouraging distribution, of this PSA as a resource to encourage EMS providers to receive the COVID-19 vaccine, to highlight the importance of vaccination to all public safety personnel and to the community, and to encourage the populations in the upcoming phases of the vaccination plan to be immunized ...
Source: JEMS Special Topics - January 14, 2021 Category: Emergency Medicine Authors: A.J. Heightman, MPA, EMT-P Tags: Commentary Coronavirus Spotlight EMS EMT Medicine Paramedic Source Type: news

Bilateral Pulmonary Embolism While Receiving Tranexamic Acid Bilateral Pulmonary Embolism While Receiving Tranexamic Acid
This case of bilateral pulmonary embolism in a healthy, active middle-aged woman reinforces the possible increased risk of thromboembolism in patients receiving tranexamic acid.Journal of Medical Case Reports (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 13, 2021 Category: Consumer Health News Tags: Family Medicine/Primary Care Journal Article Source Type: news

Screen COPD Patients With Worsening Lung Function for Pulmonary Embolism? Screen COPD Patients With Worsening Lung Function for Pulmonary Embolism?
About 6% of patients with chronic obstructive pulmonary disease who are admitted to the hospital with worsening respiratory symptoms will have pulmonary embolism, new research from France suggests.Reuters Health Information (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - January 6, 2021 Category: Intensive Care Tags: Pulmonary Medicine News Source Type: news

Approaches in Prehospital Sepsis Screening
Discussion In the United States, sepsis is one of the leading causes of death, which requires timely identification and proper treatment (CDC, 2019; Guerra et al., 2020; Polito et al., 2015). Based upon a review of literature conducted from 2014 to 2018, the primary investigators could locate five prehospital EMS screening tools to assist EMS providers in identifying at-risk sepsis patients. The researchers explored how the modified SIRS and qSOFA scoring systems were used in hospital settings in addition to these five prehospital EMS screening tools. The Bas 90-30-90, Guerra, PRESEP, PRESS, and Robson tools have ove...
Source: JEMS Patient Care - January 5, 2021 Category: Emergency Medicine Authors: JEMS Staff Tags: Exclusives Patient Care EMS EMT Paramedic Prehospital Sepsis Source Type: news

Approaches in Prehospital Sepsis Screening
Discussion In the United States, sepsis is one of the leading causes of death, which requires timely identification and proper treatment (CDC, 2019; Guerra et al., 2020; Polito et al., 2015). Based upon a review of literature conducted from 2014 to 2018, the primary investigators could locate five prehospital EMS screening tools to assist EMS providers in identifying at-risk sepsis patients. The researchers explored how the modified SIRS and qSOFA scoring systems were used in hospital settings in addition to these five prehospital EMS screening tools. The Bas 90-30-90, Guerra, PRESEP, PRESS, and Robson tools have ove...
Source: JEMS Administration and Leadership - January 5, 2021 Category: Emergency Medicine Authors: JEMS Staff Tags: Exclusives Patient Care EMS EMT Paramedic Prehospital Sepsis Source Type: news

Approaches in Prehospital Sepsis Screening
Discussion In the United States, sepsis is one of the leading causes of death, which requires timely identification and proper treatment (CDC, 2019; Guerra et al., 2020; Polito et al., 2015). Based upon a review of literature conducted from 2014 to 2018, the primary investigators could locate five prehospital EMS screening tools to assist EMS providers in identifying at-risk sepsis patients. The researchers explored how the modified SIRS and qSOFA scoring systems were used in hospital settings in addition to these five prehospital EMS screening tools. The Bas 90-30-90, Guerra, PRESEP, PRESS, and Robson tools have ove...
Source: JEMS Latest News - January 5, 2021 Category: Emergency Medicine Authors: JEMS Staff Tags: Exclusives Patient Care EMS EMT Paramedic Prehospital Sepsis Source Type: news

Approaches in Prehospital Sepsis Screening
Discussion In the United States, sepsis is one of the leading causes of death, which requires timely identification and proper treatment (CDC, 2019; Guerra et al., 2020; Polito et al., 2015). Based upon a review of literature conducted from 2014 to 2018, the primary investigators could locate five prehospital EMS screening tools to assist EMS providers in identifying at-risk sepsis patients. The researchers explored how the modified SIRS and qSOFA scoring systems were used in hospital settings in addition to these five prehospital EMS screening tools. The Bas 90-30-90, Guerra, PRESEP, PRESS, and Robson tools have ove...
Source: JEMS: Journal of Emergency Medical Services News - January 5, 2021 Category: Emergency Medicine Authors: JEMS Staff Tags: Exclusives Patient Care EMS EMT Paramedic Prehospital Sepsis Source Type: news

Approaches in Prehospital Sepsis Screening
Discussion In the United States, sepsis is one of the leading causes of death, which requires timely identification and proper treatment (CDC, 2019; Guerra et al., 2020; Polito et al., 2015). Based upon a review of literature conducted from 2014 to 2018, the primary investigators could locate five prehospital EMS screening tools to assist EMS providers in identifying at-risk sepsis patients. The researchers explored how the modified SIRS and qSOFA scoring systems were used in hospital settings in addition to these five prehospital EMS screening tools. The Bas 90-30-90, Guerra, PRESEP, PRESS, and Robson tools have ove...
Source: JEMS Operations - January 5, 2021 Category: Emergency Medicine Authors: JEMS Staff Tags: Exclusives Patient Care EMS EMT Paramedic Prehospital Sepsis Source Type: news

Approaches in Prehospital Sepsis Screening
Discussion In the United States, sepsis is one of the leading causes of death, which requires timely identification and proper treatment (CDC, 2019; Guerra et al., 2020; Polito et al., 2015). Based upon a review of literature conducted from 2014 to 2018, the primary investigators could locate five prehospital EMS screening tools to assist EMS providers in identifying at-risk sepsis patients. The researchers explored how the modified SIRS and qSOFA scoring systems were used in hospital settings in addition to these five prehospital EMS screening tools. The Bas 90-30-90, Guerra, PRESEP, PRESS, and Robson tools have ove...
Source: JEMS Special Topics - January 5, 2021 Category: Emergency Medicine Authors: JEMS Staff Tags: Exclusives Patient Care EMS EMT Paramedic Prehospital Sepsis Source Type: news

Assessment of neutrophil extracellular traps in coronary thrombus of case series of patients with COVID-19
(JAMA Network) Severe COVID-19 is characterized by the intense formation of neutrophil extracellular traps (NETs), leading to the blockage of microvessels, as shown in pulmonary samples. The occurrence of ST-elevated myocardial infarction (STEMI) is a serious cardiac manifestation of COVID-19; the intrinsic mechanism of coronary thrombosis appears to still be unknown. This case series report of five patients sought to   determine the role of NETs in coronary thrombosis in patients with COVID-19. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - December 29, 2020 Category: Infectious Diseases Source Type: news

RSNA says 29K attended 2020 virtual meeting
Over 29,000 radiology professionals from 134 countries around the world attended...Read more on AuntMinnie.comRelated Reading: RSNA 2020 wrap-up: Missing the RSNA traditions Does RSNA 2020 measure up for vendors? RSNA awards Margulis prize to COVID-19 paper RSNA announces pulmonary embolism challenge winners How to work the virtual RSNA conference (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - December 15, 2020 Category: Radiology Source Type: news

Aidoc and Imbio team up on AI for pulmonary embolism
Artificial intelligence (AI) software developers Aidoc and Imbio have formed...Read more on AuntMinnie.comRelated Reading: New AI lab at UMass focuses on thoracic imaging Siemens adds Imbio AI apps to syngo.via platform FDA clears Aidoc's incidental PE AI algorithm Imbio teams up with Genentech for AI in lung disease Aidoc secures European contract FDA OKs use of Aidoc AI software for COVID-19 (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - December 8, 2020 Category: Radiology Source Type: news

RSNA awards Margulis prize to COVID-19 paper
The RSNA has awarded its Alexander R. Margulis Award for Scientific Excellence...Read more on AuntMinnie.comRelated Reading: RSNA announces pulmonary embolism challenge winners RSNA names PE as 2020 AI challenge topic RSNA unveils plans for virtual technical exhibition RSNA addresses COVID-19 impact on private practice RSNA wins grant to develop learning center in Africa (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - November 29, 2020 Category: Radiology Source Type: news

RSNA announces pulmonary embolism challenge winners
RSNA in collaboration with the Society for Thoracic Radiology (STR) has announced...Read more on AuntMinnie.comRelated Reading: COVID-19, AI, and dose reduction top RSNA's CT agenda How to work the virtual RSNA conference AI shows growing maturity in RSNA informatics sessions RSNA names PE as 2020 AI challenge topic ACR to develop COVID-19 imaging research registry (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - November 23, 2020 Category: Radiology Source Type: news

Rates of VTE, Major Bleeding High in Primary CNS Lymphoma
Pulmonary embolism and major bleeding linked to increased mortality risk (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - November 20, 2020 Category: Cancer & Oncology Tags: Neurology, Oncology, Pharmacy, Pulmonology, Radiology, Journal, Source Type: news

Penumbra Announces Partnership with RapidAI to Enable Faster Clinical Decision-Making for Pulmonary Embolism
ALAMEDA, Calif., Nov. 10, 2020 -- (Healthcare Sales & Marketing Network) -- Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, today announced a new partnership to develop solutions to enable faster clinical decision-... Devices Penumbra Inc, RapidAI, pulmonary embolism (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 10, 2020 Category: Pharmaceuticals Source Type: news

New XARELTO ® (rivaroxaban) Peripheral Artery Disease (PAD) Data from EXPLORER Clinical Research Program to be Unveiled at American Heart Association (AHA) Scientific Sessions 2020
RARITAN, N.J., November 9, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that 10 data presentations will be shared at the virtual American Heart Association (AHA) Scientific Sessions 2020 from November 13-17. Most notably, four new sub-analyses of XARELTO® (rivaroxaban) from the landmark VOYAGER PAD trial, part of the EXPLORER global cardiovascular research program, will be presented, including two live, featured science oral presentations. “We're pleased VOYAGER PAD was selected to be front and center once again at a major medical congress, as there's an urgent need f...
Source: Johnson and Johnson - November 9, 2020 Category: Pharmaceuticals Tags: Innovation Source Type: news

Janssen Headlines American Society of Hematology Annual Meeting With More Than 35 Presentations Highlighting Deep, Diverse Oncology Pipeline and Portfolio
RARITAN, N.J., November 5, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today more than 35 company-sponsored studies, including 10 oral presentations, will be featured at the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition taking place virtually December 5-8, 2020.In multiple myeloma, highlights include Phase 1b/2 results for the B-cell maturation antigen (BCMA)-targeted chimeric antigen receptor T-cell (CAR-T) therapy ciltacabtagene autoleucel (cilta-cel); new and updated data for the anti-CD38 monoclonal antibody DARZALEX® (daratumumab) and the subcutane...
Source: Johnson and Johnson - November 5, 2020 Category: Pharmaceuticals Tags: Innovation Source Type: news

Clots in COVID-19 Tied to Illness Severity, Not Virus Itself Clots in COVID-19 Tied to Illness Severity, Not Virus Itself
COVID-19 does not independently increase the risk of pulmonary embolism (PE), new findings suggest.Reuters Health Information (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - November 5, 2020 Category: Intensive Care Tags: Cardiology News Source Type: news

Majority Of Hospitalized Coronavirus Patients Left With Heart Abnormalities, Study Finds
cbsoptanon.onScriptsReady(function(cmp){cmp.ot.targetingAllowed(function(a){if(a) AnvatoPlayer("p1").init({"mcp":"cbs","width":"100%","height":"100%","video":"4821234","autoplay":false,"titleVisible":false,"accessKey":"EZqvRyKE7qmqDflDPXIw6U7kKZEA0Vx7","accessControl":{"preview":false},"pInstance":"p1","plugins":{"heartbeat":{"account":"cbslocal-global-unified","publisherId":"cbslocal","jobId...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - October 26, 2020 Category: Consumer Health News Authors: Health – CBS Boston Tags: Boston News Covid-19 Boston, MA Health Syndicated CBSN Boston Syndicated Local Coronavirus Dr. Mallika Marshall Source Type: news

Janssen Submits Application to U.S. FDA for New Indication to Expand Use of XARELTO ® (rivaroxaban) in Patients with Peripheral Artery Disease
RARITAN, NJ, October 26, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today it has submitted a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) for a new indication to expand the use of XARELTO® (rivaroxaban) in patients with peripheral artery disease (PAD). If approved, this new indication for the XARELTO® vascular dose (2.5 mg twice daily plus aspirin 75-100 mg once daily) would include reducing the risk of major thrombotic vascular events such as heart attack, stroke and amputation in patients after recent lower-extremity revasculariz...
Source: Johnson and Johnson - October 26, 2020 Category: Pharmaceuticals Tags: Innovation Source Type: news

DVT Screening, Early Treatment, Prevent PE in Necrotizing Pancreatitis DVT Screening, Early Treatment, Prevent PE in Necrotizing Pancreatitis
Ultrasound screening enabled identification and early treatment of extremity deep vein thrombosis (DVT), thereby preventing symptomatic pulmonary embolism (PE) in a single center trial.Reuters Health Information (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - October 23, 2020 Category: Gastroenterology Tags: General Surgery News Source Type: news

Imaging analysis AI startups announce 510(k)s for prostate cancer, incidental pulmonary embolism algorithms
Quantib and Ezra's automated tools support diagnosis and measurement of the prostate and prostate lesions, while Aidoc's algorithm acts as an always-on catch net for unsuspected blockage of pulmonary arteries. (Source: mobihealthnews)
Source: mobihealthnews - October 21, 2020 Category: Information Technology Source Type: news

The Most Important Things To Know About Blood Clots
Blood clots are responsible for one in four deaths globally if you include heart attacks and strokes, but people working from home may be at higher risk for pulmonary embolism too. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - October 14, 2020 Category: Pharmaceuticals Authors: Tara Haelle, Senior Contributor Tags: Healthcare /healthcare Innovation /innovation business pharma Source Type: news

Pulmonary artery thrombosis a complication of radiation therapy
(American Roentgen Ray Society) According to ARRS' American Journal of Roentgenology, the imaging findings of in situ pulmonary artery thrombosis (PAT) associated with radiation therapy (RT) are different from those of acute pulmonary emboli and do not appear to embolize. Due to the differences in clinical prognosis and subsequent management strategies, in situ PAT associated with RT -- which has not previously been described in the English literature -- must be distinguished from pulmonary embolism. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 9, 2020 Category: Cancer & Oncology Source Type: news

When Loved One Is in ICU, Spouse Sees Health Risks
Compared to others, those with a spouse in the ICU had increased odds of an event such as chest pain, heart attack, stroke, irregular heart rhythm, heart failure or a blood clot in the lungs (pulmonary embolism) within a month. (Source: WebMD Health)
Source: WebMD Health - October 5, 2020 Category: Consumer Health News Source Type: news

HOME-PE Trial Clarifies Which PE Patients to Treat at Home HOME-PE Trial Clarifies Which PE Patients to Treat at Home
The randomized HOME-PE trial clarifies a transatlantic controversy regarding how best to triage patients with acute pulmonary embolism for outpatient care. Hestia criteria proved as safe as sPESI score.Medscape Medical News (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - September 1, 2020 Category: Internal Medicine Tags: Cardiology News Source Type: news

Hospitalized COVID-19 Patients and Venous Thromboembolism Hospitalized COVID-19 Patients and Venous Thromboembolism
Early reports indicate that a very high proportion of critically ill patients hospitalized with COVID-19 will experience venous thromboembolism, particularly pulmonary embolism.Circulation (Source: Medscape Radiology Headlines)
Source: Medscape Radiology Headlines - August 28, 2020 Category: Radiology Tags: Infectious Diseases Journal Article Source Type: news

Finer Risk Stratification Key in Acute Pulmonary Embolism Finer Risk Stratification Key in Acute Pulmonary Embolism
Patients with intermediate- to low-risk PE, and those with low-risk PE, require anticoagulation only. In contrast, patients with intermediate- to high-risk PE are at increased risk of decompensation.Medscape Medical News (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - August 19, 2020 Category: Internal Medicine Tags: Hospital Medicine News Source Type: news

Embelin ameliorated sepsis-induced disseminated intravascular coagulation intensities by simultaneously suppressing inflammation and thrombosis
In this study, we used three thrombotic mice models to confirm the antithrombotic property of embelin. By combining the anti-inflammatory and the antithrombotic properties, we proposed embelin as a potent therapeutic agent for sepsis-induced DIC, which involves both inflammation and thrombosis. In a lipopolysaccharides-induced septic mice model, embelin not only significantly ameliorated the inflammation levels, but also effectively reduced the pulmonary hemorrhages and the micro-thrombi formations in lung. In contrast, low-molecular-weight-heparin, an anticoagulant, only moderately ameliorated the pulmonary hemorrhages an...
Source: Current Awareness Service for Health (CASH) - August 5, 2020 Category: Consumer Health News Source Type: news

What Are Some Pediatric Oncological Emergencies?
Discussion Pediatric cancers in the US number about 12,000 per year. After injury, it is the second leading cause of death in children and adolescents. Cancer presentations vary widely, but often begin with non-specific symptoms that continue or progress depending on the location and tumor type. Patients can present with oncological emergencies especially if there are mechanical obstruction such as superior vena cava syndrome or cerebral herniation. More commonly are infections due to immunosuppression. Cancer treatment also causes its own myriad of problems that clinicians need to be aware of to diagnosis and treat, but a...
Source: PediatricEducation.org - July 20, 2020 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

Alembic Pharma gets tentative USFDA nod for generic Rivaroxaban tablets
Rivaroxaban tablets are indicated for multiple conditions, including reduction of risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation; treatment of deep vein thrombosis (DVT) and treatment of pulmonary embolism (PE). (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - June 21, 2020 Category: Pharmaceuticals Source Type: news

Barriers exist to using risk stratification tools to evaluate pulmonary embolism in the ED
(Society for Academic Emergency Medicine) Common barriers exist to the use of risk stratification tools in the evaluation of pulmonary embolism in the emergency department and provide insight into where to focus efforts for future implementation endeavors. That is the conclusion of a study to be published in the June 2020 issue of Academic Emergency Medicine (AEM), a journal of the Society for Academic Emergency Medicine (SAEM). (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 15, 2020 Category: International Medicine & Public Health Source Type: news

DoD Funds Clinical Trial of Seraph Blood Filter to Treat COVID-19
The Department of Defense is funding a clinical trial of a COVID-19 treatment using ExThera Medical’s Seraph 100 Blood filter. The device was selected to be in the multi-center randomized clinical trial because it showed encouraging preliminary results in critically ill COVID-19 patients at a military hospital in the U.S. and 14 other hospitals in Europe. Investigators at the Uniformed Services University in Bethesda will run the trial of the Martinez, CA-based company’s device. Initial reports indicate Seraph 100 stabilizes blood pressure and inflammatory biomarkers that correlate with ...
Source: MDDI - June 10, 2020 Category: Medical Devices Authors: Omar Ford Tags: COVID-19 Business Source Type: news

Devices Will Play A Greater Role in COVID-19
Up until now, medical devices have been in the background when it comes to the novel coronavirus. The bigger stories in the industry came from diagnostic firms either developing virus detection or antibody tests.   However, that all changed when Danvers, MA-based Abiomed was granted Emergency Use Authorization for the Impella RP to include patients suffering from COVID-19 related right heart failure or decompensation, including pulmonary embolism.   I give my take on why this lone EUA could be the start of more device-related solutions regarding symptoms associated with COVID-19.   &Acir...
Source: MDDI - June 8, 2020 Category: Medical Devices Tags: COVID-19 Source Type: news

Abiomed Granted IDE to Evaluate ‘World’s Smallest Heart Pump’
Abiomed said it has received approval for an IDE to start an early feasibility study of what it is calling the “world’s smallest heart pump.”   The Danvers, MA-based company said the first-in-human trial will look at the 9 French Impella ECP heart pump in high-risk percutaneous coronary intervention (PCI) patients.   The primary endpoint of the study is successful delivery, initiation, and maintenance of adequate hemodynamic support and a composite rate of major device-related adverse events during high-risk PCI.   The stu...
Source: MDDI - June 6, 2020 Category: Medical Devices Tags: Cardiovascular Regulatory and Compliance Source Type: news

Thrombosis in COVID-19: clinical outcomes, biochemical and pathological changes, and treatments, CEBM
Reports that COVID-19 is associated with venous and arterial thrombosis and pulmonary embolism and increased rates of thrombosis in cannulae and extracorporeal circuits for renal replacement or membrane oxygenation, have drawn attention to the coagulant effects of the disease. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - June 4, 2020 Category: Consumer Health News Source Type: news

Pulmonary embolism and COVID-19
(Henry Ford Health System) Researchers at Henry Ford Health System in Detroit say early diagnosis of a life-threatening blood clot in the lungs led to swifter treatment intervention in COVID-19 patients. In a new study published recently in the journal Radiology, researchers found that 51 percent of patients found to have a pulmonary embolism, or PE, were diagnosed in the Emergency Department, the entry point for patients being admitted to the hospital. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 2, 2020 Category: Infectious Diseases Source Type: news

New EUA Places Abiomed Firmly in the COVID-19 Conversation
Sometimes when the discussion of tackling the novel coronavirus comes up, the use of medical devices gets lost in the shuffle. Most of the conversation surrounding COVID-19 comes from either the promise of a vaccine or the expansion of tests. Abiomed is adding to the conversation surrounding medtech’s potential contribution to the treatment of COVID-19 patients. Monday, the Danvers, MA-based company by receiving Emergency Use Authorization for a device to treat COVID-19 related right heart failure patients. The Impella RP is a temporary heart pump that provides circulatory support for patients who develop...
Source: MDDI - June 2, 2020 Category: Medical Devices Authors: Omar Ford Tags: Cardiovascular COVID-19 Source Type: news

FDA Issues Emergency Use Authorization for Impella RP in COVID-19 FDA Issues Emergency Use Authorization for Impella RP in COVID-19
The authorization allows use of the temporary heart pump in the treatment of right heart failure or decompensation, including pulmonary embolism, caused by COVID-19 complications.FDA Approvals (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - June 1, 2020 Category: Cardiology Tags: Cardiology News Alert Source Type: news

Odds of Pulmonary Embolism Up for Obese COVID - 19 Patients
Odds of developing PE lower for COVID - 19 patients taking statin therapy prior to admission (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - May 20, 2020 Category: Respiratory Medicine Tags: Infections, Pulmonology, Radiology, Critical Care, Emergency Medicine, Journal, Source Type: news

Obesity Ups Odds for Lung Clots in COVID Patients
Researchers said that obese patients with COVID-19 may have nearly three times the risk of developing what is known as a pulmonary embolism. (Source: WebMD Health)
Source: WebMD Health - May 20, 2020 Category: Consumer Health News Source Type: news

Odds of Pulmonary Embolism Up for Obese COVID-19 Patients
WEDNESDAY, May 20, 2020 -- Patients with COVID-19 with a body mass index (BMI)>30 kg/m² have increased odds of developing pulmonary embolism (PE), according to a research letter published online May 14 in Radiology. Neo Poyiadi, M.D., from... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 20, 2020 Category: Pharmaceuticals Source Type: news

Could COVID-19 Finally Destigmatize Mental Illness?
There is a research model going around that suggests as many as 150,000 additional people could die from mental health-related outcomes of COVID-19. I could argue the merits of the mathematical model as many of my colleagues have. I could also make the case that discussing the depths of despair and predicting increasing suicide rates over and over could, in fact, lead to copycat suicides. But what if I took an alternative stance, and told you that—though absolutely no one would wish a pandemic on anyone— this is actually what mental health needed to stop being stigmatized and start being valued? I’m not ...
Source: TIME: Health - May 13, 2020 Category: Consumer Health News Authors: Jessica Gold Tags: Uncategorized COVID-19 Source Type: news

High Rate of Pulmonary Embolism Found for Patients With COVID - 19
Two studies demonstrate high rate of PE; 100 percent sensitivity for PE seen for D - dimer level> 2,660 µ g/L (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - April 28, 2020 Category: Respiratory Medicine Tags: Family Medicine, Infections, Internal Medicine, Critical Care, Emergency Medicine, Pulmonology, Radiology, Journal, Source Type: news